TNSN04138A1 - Metabolites de l'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino] - methyl}-phenoxy)-acetique - Google Patents
Metabolites de l'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino] - methyl}-phenoxy)-acetiqueInfo
- Publication number
- TNSN04138A1 TNSN04138A1 TNP2004000138A TNSN04138A TNSN04138A1 TN SN04138 A1 TNSN04138 A1 TN SN04138A1 TN P2004000138 A TNP2004000138 A TN P2004000138A TN SN04138 A TNSN04138 A TN SN04138A TN SN04138 A1 TNSN04138 A1 TN SN04138A1
- Authority
- TN
- Tunisia
- Prior art keywords
- sulfonyl
- phenoxy
- pyridine
- amino
- methyl
- Prior art date
Links
- -1 PYRIDINE-3-SULFONYL Chemical class 0.000 title abstract 2
- 125000003352 4-tert-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne des métabolites d'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino]-méthyl}-phénoxy)-acétique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35374802P | 2002-01-31 | 2002-01-31 | |
PCT/IB2003/000121 WO2003064391A1 (fr) | 2002-01-31 | 2003-01-20 | Metabolites d'acide (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetique |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN04138A1 true TNSN04138A1 (fr) | 2007-03-12 |
Family
ID=27663249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2004000138A TNSN04138A1 (fr) | 2002-01-31 | 2004-07-27 | Metabolites de l'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino] - methyl}-phenoxy)-acetique |
Country Status (29)
Country | Link |
---|---|
US (1) | US6852863B2 (fr) |
EP (1) | EP1470109A1 (fr) |
JP (1) | JP2005521668A (fr) |
KR (1) | KR20040077884A (fr) |
CN (1) | CN1625549A (fr) |
AP (1) | AP2004003094A0 (fr) |
AR (1) | AR038332A1 (fr) |
BR (1) | BR0307339A (fr) |
CA (1) | CA2473984A1 (fr) |
EA (1) | EA200400724A1 (fr) |
EC (1) | ECSP045215A (fr) |
GB (1) | GB2400100B (fr) |
HN (1) | HN2003000051A (fr) |
HR (1) | HRP20040683A2 (fr) |
HU (1) | HUP0500012A2 (fr) |
IL (1) | IL162167A0 (fr) |
IS (1) | IS7281A (fr) |
MA (1) | MA27169A1 (fr) |
MX (1) | MXPA04004960A (fr) |
NO (1) | NO20043569D0 (fr) |
OA (1) | OA12760A (fr) |
PA (1) | PA8564601A1 (fr) |
PE (1) | PE20030978A1 (fr) |
PL (1) | PL371982A1 (fr) |
TN (1) | TNSN04138A1 (fr) |
TW (1) | TW200302080A (fr) |
UY (1) | UY27632A1 (fr) |
WO (1) | WO2003064391A1 (fr) |
ZA (1) | ZA200404067B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
TWI332937B (en) * | 2005-04-20 | 2010-11-11 | Lg Chemical Ltd | Additive for non-aqueous electrolyte and secondary battery using the same |
JP4583500B2 (ja) * | 2006-07-28 | 2010-11-17 | ファイザー・プロダクツ・インク | Ep2作動薬 |
WO2008112164A2 (fr) | 2007-03-08 | 2008-09-18 | The Board Of Trustees Of The Leland Stanford Junior University | Modulateurs de l'aldéhyde déshydrogénase-2 mitochondrial, et leurs procédés d'utilisation |
EP2002834A1 (fr) * | 2007-06-13 | 2008-12-17 | Bayer Schering Pharma Aktiengesellschaft | Aryle/hétarylamides en tant que modulateurs du récepteur EP2 |
DK2264009T3 (en) * | 2008-03-12 | 2019-04-15 | Ube Industries | PYRIDYLAMINE ACEDIC ACID COMPOUND |
EP2149551A1 (fr) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | Dérivés de N-(indol-3-ylalkyl)-(hétéro)arylamide en tant que modulateurs du récepteur EP2 |
EP2149552A1 (fr) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | Dérivés de benzamide 5,6 substitués en tant que modulateurs du récepteur EP2 |
EP2149554A1 (fr) | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma Aktiengesellschaft | Indolylamides en tant que modulateurs du récepteur EP2 |
JP2012502048A (ja) | 2008-09-08 | 2012-01-26 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法 |
KR20110082180A (ko) | 2008-10-28 | 2011-07-18 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | 알데히드 탈수소효소의 조절자 및 그것의 사용방법 |
SI2415763T1 (sl) | 2009-03-30 | 2016-05-31 | Ube Industries, Ltd. | Farmacevtski sestavek za zdravljenje ali preprečevanje glavkoma |
DE102009049662A1 (de) | 2009-10-13 | 2011-04-14 | Bayer Schering Pharma Aktiengesellschaft | 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten |
WO2012149106A1 (fr) | 2011-04-29 | 2012-11-01 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions et procédés d'augmentation de la prolifération de cellules souches salivaires adultes |
TW201326154A (zh) | 2011-11-28 | 2013-07-01 | 拜耳知識產權公司 | 作為ep2受體拮抗劑之新穎2h-吲唑 |
JP6410790B2 (ja) | 2013-03-14 | 2018-10-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA67754C2 (uk) | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
-
2003
- 2003-01-20 MX MXPA04004960A patent/MXPA04004960A/es unknown
- 2003-01-20 PL PL03371982A patent/PL371982A1/xx not_active Application Discontinuation
- 2003-01-20 BR BR0307339-4A patent/BR0307339A/pt not_active IP Right Cessation
- 2003-01-20 EA EA200400724A patent/EA200400724A1/ru unknown
- 2003-01-20 GB GB0413967A patent/GB2400100B/en not_active Expired - Fee Related
- 2003-01-20 CA CA002473984A patent/CA2473984A1/fr not_active Abandoned
- 2003-01-20 IL IL16216703A patent/IL162167A0/xx unknown
- 2003-01-20 AP APAP/P/2004/003094A patent/AP2004003094A0/en unknown
- 2003-01-20 JP JP2003564014A patent/JP2005521668A/ja active Pending
- 2003-01-20 EP EP03700072A patent/EP1470109A1/fr not_active Withdrawn
- 2003-01-20 WO PCT/IB2003/000121 patent/WO2003064391A1/fr active Application Filing
- 2003-01-20 CN CNA038029952A patent/CN1625549A/zh active Pending
- 2003-01-20 OA OA1200400198A patent/OA12760A/en unknown
- 2003-01-20 KR KR10-2004-7011618A patent/KR20040077884A/ko not_active Application Discontinuation
- 2003-01-20 HU HU0500012A patent/HUP0500012A2/hu unknown
- 2003-01-24 TW TW092101619A patent/TW200302080A/zh unknown
- 2003-01-28 PE PE2003000086A patent/PE20030978A1/es not_active Application Discontinuation
- 2003-01-28 HN HN2003000051A patent/HN2003000051A/es unknown
- 2003-01-29 AR ARP030100254A patent/AR038332A1/es unknown
- 2003-01-29 US US10/353,671 patent/US6852863B2/en not_active Expired - Fee Related
- 2003-01-30 UY UY27632A patent/UY27632A1/es not_active Application Discontinuation
- 2003-01-30 PA PA20038564601A patent/PA8564601A1/es unknown
-
2004
- 2004-05-21 IS IS7281A patent/IS7281A/is unknown
- 2004-05-25 ZA ZA200404067A patent/ZA200404067B/en unknown
- 2004-07-21 MA MA27796A patent/MA27169A1/fr unknown
- 2004-07-23 HR HR20040683A patent/HRP20040683A2/hr not_active Application Discontinuation
- 2004-07-27 TN TNP2004000138A patent/TNSN04138A1/fr unknown
- 2004-07-30 EC EC2004005215A patent/ECSP045215A/es unknown
- 2004-08-26 NO NO20043569A patent/NO20043569D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0500012A2 (hu) | 2005-04-28 |
GB0413967D0 (en) | 2004-07-28 |
CN1625549A (zh) | 2005-06-08 |
US6852863B2 (en) | 2005-02-08 |
OA12760A (en) | 2006-07-04 |
KR20040077884A (ko) | 2004-09-07 |
WO2003064391A1 (fr) | 2003-08-07 |
ZA200404067B (en) | 2005-08-29 |
GB2400100A (en) | 2004-10-06 |
AP2004003094A0 (en) | 2004-09-30 |
MXPA04004960A (es) | 2005-04-08 |
JP2005521668A (ja) | 2005-07-21 |
BR0307339A (pt) | 2004-12-07 |
PA8564601A1 (es) | 2003-09-05 |
IL162167A0 (en) | 2005-11-20 |
HN2003000051A (es) | 2003-09-24 |
US20030216445A1 (en) | 2003-11-20 |
IS7281A (is) | 2004-05-21 |
CA2473984A1 (fr) | 2003-08-07 |
ECSP045215A (es) | 2004-09-28 |
TW200302080A (en) | 2003-08-01 |
GB2400100B (en) | 2006-04-12 |
NO20043569L (no) | 2004-08-26 |
AR038332A1 (es) | 2005-01-12 |
EA200400724A1 (ru) | 2004-12-30 |
NO20043569D0 (no) | 2004-08-26 |
PL371982A1 (en) | 2005-07-11 |
EP1470109A1 (fr) | 2004-10-27 |
PE20030978A1 (es) | 2003-11-19 |
HRP20040683A2 (en) | 2004-10-31 |
UY27632A1 (es) | 2003-08-29 |
MA27169A1 (fr) | 2005-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN04138A1 (fr) | Metabolites de l'acide (3-{[4-tertiobutylbenzyl)-(pyridine-3-sulfonyl)-amino] - methyl}-phenoxy)-acetique | |
EA200500017A1 (ru) | Новые соединения | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
MA29369B1 (fr) | Dosage fixe d'anticorps anti-her | |
NO20041493L (no) | Kjemiske forbindelser. | |
CY1107400T1 (el) | Συνταγοποιηση κοκκου μοντελουκαστης | |
EA199900373A2 (ru) | Фармацевтические композиции | |
DK1193270T3 (da) | Pyrrolobenzodiazepiner | |
DK2014304T3 (da) | Kolonrensende sammensætninger | |
CY1108567T1 (el) | Αντιθρομβωτικες ενωσεις | |
BRPI0414593A (pt) | derivados de ácido sulfonamida substituìda-indol-2-carboxìlico como inibidores de pai-1 | |
SE0203713D0 (sv) | Novel compounds | |
BR0014651A (pt) | Inibidores de adesão de célula mediada por "alfa" l beta2 | |
NO20042534L (no) | Forbedringer vedrorende optiske lysgjoringsmidler | |
PE20011085A1 (es) | Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos | |
ATE438398T1 (de) | Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren | |
SE9901077D0 (sv) | Novel use | |
ATE285753T1 (de) | Lysin enthaltende kautablette | |
BR0008112A (pt) | Agonistas de 5-ht 1f | |
SV2003000981A (es) | Fenil-heterociclil-eteres ref. pcs10973 | |
DE60332432D1 (de) | Ibuprofen-lösung für hartschalenkapseln | |
BR0307978A (pt) | Composição alvejante | |
DE60124717D1 (de) | Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit | |
PT1206452E (pt) | Processo de preparacao de compostos benzoper-hidroisoindole | |
AR027349A1 (es) | Derivados de amidas heterociclicas |